Selected research
Industry Growth & Trends
Global Pet Tumor Screening Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Pet Tumor Screening Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pet Tumor Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pet Tumor Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pet Tumor Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Pet Tumor Screening Service market include PetDx, CYTOGEN, BioChain, Small Door, ANGLE, BioChain Institute Inc., CANCAN DIAGNOSTICS., IDEXX Laboratories and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pet Tumor Screening Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pet Tumor Screening Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pet Tumor Screening Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pet Tumor Screening Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Pet Tumor Screening Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pet Tumor Screening Service Market by Company
PetDx
CYTOGEN
BioChain
Small Door
ANGLE
BioChain Institute Inc.
CANCAN DIAGNOSTICS.
IDEXX Laboratories
Zoetis
Pet Tumor Screening Service Segment by Type
Cut Biopsy
Needle Biopsy
Pet Tumor Screening Service Segment by Application
Pet Hospital
Clinic
Scientific Research Institutions
Pet Tumor Screening Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Tumor Screening Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Tumor Screening Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Tumor Screening Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Pet Tumor Screening Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Cut Biopsy
- Needle Biopsy
Applications
- Pet Hospital
- Clinic
- Scientific Research Institutions
Companies covered
- PetDx
- CYTOGEN
- BioChain
- Small Door
- ANGLE
- BioChain Institute Inc.
- CANCAN DIAGNOSTICS.
- IDEXX Laboratories
- Zoetis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Pet Tumor Screening Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Pet Tumor Screening Service Market Size by Region (2021-2032)
- 1.4.1 Global Pet Tumor Screening Service Market Size by Region (2021-2026)
- 1.4.2 Global Pet Tumor Screening Service Market Size by Region (2027-2032)
- 1.5 Key Regions Pet Tumor Screening Service Market Size (2021-2032)
- 1.5.1 North America Pet Tumor Screening Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Pet Tumor Screening Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Pet Tumor Screening Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Pet Tumor Screening Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Pet Tumor Screening Service Market Size Growth Rate (2021-2032)
2 Pet Tumor Screening Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Cut Biopsy
- 2.1.2 Needle Biopsy
- 2.2 Global Pet Tumor Screening Service Market Size by Type
- 2.2.1 Global Pet Tumor Screening Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Pet Tumor Screening Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Pet Tumor Screening Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Pet Tumor Screening Service Market Size by Regions
- 2.3.1 North America Pet Tumor Screening Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Pet Tumor Screening Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Pet Tumor Screening Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Pet Tumor Screening Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Pet Tumor Screening Service Market Size Breakdown by Type (2021-2026)
3 Pet Tumor Screening Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Pet Hospital
- 3.1.2 Clinic
- 3.1.3 Scientific Research Institutions
- 3.2 Global Pet Tumor Screening Service Market Size by Application
- 3.2.1 Global Pet Tumor Screening Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Pet Tumor Screening Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Pet Tumor Screening Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Pet Tumor Screening Service Market Size by Regions
- 3.3.1 North America Pet Tumor Screening Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Pet Tumor Screening Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Pet Tumor Screening Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Pet Tumor Screening Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Pet Tumor Screening Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Pet Tumor Screening Service Industry Trends
- 4.2 Pet Tumor Screening Service Industry Drivers
- 4.3 Pet Tumor Screening Service Industry Opportunities and Challenges
- 4.4 Pet Tumor Screening Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Pet Tumor Screening Service Revenue (2021-2026)
- 5.2 Global Pet Tumor Screening Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Pet Tumor Screening Service Key Company Headquarters & Area Served
- 5.4 Global Pet Tumor Screening Service Company, Product Type & Application
- 5.5 Global Pet Tumor Screening Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Pet Tumor Screening Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Pet Tumor Screening Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Pet Tumor Screening Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 PetDx
- 6.1.1 PetDx Company Information
- 6.1.2 PetDx Business Overview
- 6.1.3 PetDx Pet Tumor Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 PetDx Pet Tumor Screening Service Product Portfolio
- 6.1.5 PetDx Recent Developments
- 6.2 CYTOGEN
- 6.2.1 CYTOGEN Company Information
- 6.2.2 CYTOGEN Business Overview
- 6.2.3 CYTOGEN Pet Tumor Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 CYTOGEN Pet Tumor Screening Service Product Portfolio
- 6.2.5 CYTOGEN Recent Developments
- 6.3 BioChain
- 6.3.1 BioChain Company Information
- 6.3.2 BioChain Business Overview
- 6.3.3 BioChain Pet Tumor Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 BioChain Pet Tumor Screening Service Product Portfolio
- 6.3.5 BioChain Recent Developments
- 6.4 Small Door
- 6.4.1 Small Door Company Information
- 6.4.2 Small Door Business Overview
- 6.4.3 Small Door Pet Tumor Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Small Door Pet Tumor Screening Service Product Portfolio
- 6.4.5 Small Door Recent Developments
- 6.5 ANGLE
- 6.5.1 ANGLE Company Information
- 6.5.2 ANGLE Business Overview
- 6.5.3 ANGLE Pet Tumor Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 ANGLE Pet Tumor Screening Service Product Portfolio
- 6.5.5 ANGLE Recent Developments
- 6.6 BioChain Institute Inc.
- 6.6.1 BioChain Institute Inc. Company Information
- 6.6.2 BioChain Institute Inc. Business Overview
- 6.6.3 BioChain Institute Inc. Pet Tumor Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 BioChain Institute Inc. Pet Tumor Screening Service Product Portfolio
- 6.6.5 BioChain Institute Inc. Recent Developments
- 6.7 CANCAN DIAGNOSTICS.
- 6.7.1 CANCAN DIAGNOSTICS. Company Information
- 6.7.2 CANCAN DIAGNOSTICS. Business Overview
- 6.7.3 CANCAN DIAGNOSTICS. Pet Tumor Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 CANCAN DIAGNOSTICS. Pet Tumor Screening Service Product Portfolio
- 6.7.5 CANCAN DIAGNOSTICS. Recent Developments
- 6.8 IDEXX Laboratories
- 6.8.1 IDEXX Laboratories Company Information
- 6.8.2 IDEXX Laboratories Business Overview
- 6.8.3 IDEXX Laboratories Pet Tumor Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 IDEXX Laboratories Pet Tumor Screening Service Product Portfolio
- 6.8.5 IDEXX Laboratories Recent Developments
- 6.9 Zoetis
- 6.9.1 Zoetis Company Information
- 6.9.2 Zoetis Business Overview
- 6.9.3 Zoetis Pet Tumor Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Zoetis Pet Tumor Screening Service Product Portfolio
- 6.9.5 Zoetis Recent Developments
7 North America
- 7.1 North America Pet Tumor Screening Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Pet Tumor Screening Service Market Size by Country (2021-2026)
- 7.3 North America Pet Tumor Screening Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Pet Tumor Screening Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Pet Tumor Screening Service Market Size by Country (2021-2026)
- 8.3 Europe Pet Tumor Screening Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pet Tumor Screening Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Pet Tumor Screening Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Pet Tumor Screening Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Pet Tumor Screening Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Pet Tumor Screening Service Market Size by Country (2021-2026)
- 10.3 South America Pet Tumor Screening Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pet Tumor Screening Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Pet Tumor Screening Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Pet Tumor Screening Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst